Immunophenotype and increased presence of CD4+CD25+ regulatory T cells in patients with acute lymphoblastic leukemia

Wu,Cui-Ping; Qing,Xi; Wu,Cui-Yun; Zhu,Hong; Zhou,Hai-Yan

doi:10.3892/ol.2011.499

February 2012 Volume 3 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

February 2012 Volume 3 Issue 2

Full Size Image

Article

Immunophenotype and increased presence of CD4+CD25+ regulatory T cells in patients with acute lymphoblastic leukemia

Authors:
- Cui-Ping Wu
- Xi Qing
- Cui-Yun Wu
- Hong Zhu
- Hai-Yan Zhou
View Affiliations / Copyright

Affiliations: Department of Laboratory Medicine, Affiliated Hospital of Hainan Medical College, Haikou, Hainan 570102, P.R. China
Pages: 421-424
|
Published online on: November 29, 2011

https://doi.org/10.3892/ol.2011.499
Expand metrics +

Abstract

Acute lymphoblastic leukemia (ALL), cancer of the white blood cells, is a heterogeneous disease that mainly occurs due to the malignant cloning of original and naive lymphocytes. The aim of this study was to explore the immunophenotype, the percentage of CD4+CD25+ regulatory T cells (Tregs) and the expression of cytokines interleukin (IL)-2, IL-10 and TGF-β in patients with ALL. The immunophenotype and levels of CD4+CD25+ Tregs were detected using flow cytometry in the peripheral blood of 35 ALL patients, with 18 healthy individuals being selected as controls. The results suggested that 22 patients had B cell ALL (B-ALL) and 13 had T cell ALL (T-ALL) among the 35 ALL patients. In B-ALL patients, the surface antigen CD19 was most commonly expressed; in T-ALL patients, CD7 was most common. Furthermore, the percentage of CD4+CD25+ Treg cells in the peripheral blood of B-ALL and T-ALL patients was higher compared to that of healthy individuals (P<0.05). Additionally, IL-10 and TGF-β levels in cell culture supernatants from B-ALL and T-ALL patients were higher compared to those in the controls (P<0.05); IL-2 levels were lower in ALL patients. No significant differences were observed in the levels of CD4+CD25+ Treg cells, IL-2, IL-10 or TGF-β in B-ALL versus T-ALL patients. The authors concluded that CD19 and CD7 may serve as diagnostic markers of B-ALL and T-ALL, respectively. The increased presence of CD4+CD25+ Treg cells and the altered levels of secreted cytokines are indicative of an immunosuppressive mechanism in the pathogenesis of ALL.

View Figures

View References

1	Han X and Bueso-Ramos CE: Advances in the pathological diagnosis and biology of acute lymphoblastic leukemia. Ann Diagn Pathol. 9:239–257. 2005. View Article : Google Scholar : PubMed/NCBI
2	Onciu M: Acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 23:655–674. 2009. View Article : Google Scholar
3	Qiu Y, Wang G, Liu YJ and Shan LJ: Analysis of immunophenotypes of acute lymphoblastic leukemia by three color flow cytometry. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 17:442–444. 2009.PubMed/NCBI
4	Sakaguchi S, Sakaguchi N, Asano M, Itoh M and Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 155:1151–1164. 1995.
5	Krawczyńska A and Robak T: Monoclonal antibodies in diagnosis of acute leukemias. Przegl Lek. 53:20–25. 1996.
6	Nachman J: Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemia. Br J Haematol. 130:166–173. 2005. View Article : Google Scholar : PubMed/NCBI
7	Ou Y and Zhu P: Mechanism of CD4⁺CD25⁺ and CD8⁺ regulatory T cells − review. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 13:1137–1140. 2005.PubMed/NCBI
8	Gupta S: Immune homeostasis: regulatory T cells (Treg) and molecules. J Clin Immunol. 28:617–618. 2008. View Article : Google Scholar : PubMed/NCBI
9	Gershon RK and Kondo K: Infectious immunological tolerance. Immunology. 21:903–914. 1971.PubMed/NCBI
10	Berendt MJ and North RJ: T-cell-mediated suppression of anti-tumor immunity: an explanation for progressive growth of an immunogenic tumor. J Exp Med. 151:69–80. 1980. View Article : Google Scholar : PubMed/NCBI
11	Zhang L, Dermawan KT, Jin ML, Xiong SD and Chu YW: Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells? Med Hypotheses. 71:802–804. 2008. View Article : Google Scholar : PubMed/NCBI
12	Marshall NA, Christie LE, Munro LR, Culligan DJ, Johnston PW, Barker RN and Vickers MA: Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood. 103:1755–1762. 2004. View Article : Google Scholar : PubMed/NCBI
13	Turka LA and Walsh PT: IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells. Front Biosci. 13:1440–1446. 2008.
14	Sabat R, Grütz G, Warszawska K, Kirsch S, Witte E, Wolk K and Geginat J: Biology of interleukin-10. Cytokine Growth Factor Rev. 21:331–344. 2010. View Article : Google Scholar
15	Meulmeester E and Ten Dijke P: The dynamic roles of TGF-β in cancer. J Pathol. 223:205–218. 2011.